CN201269874Y - Hemolytic agent charging apparatus - Google Patents

Hemolytic agent charging apparatus Download PDF

Info

Publication number
CN201269874Y
CN201269874Y CNU2008202124418U CN200820212441U CN201269874Y CN 201269874 Y CN201269874 Y CN 201269874Y CN U2008202124418 U CNU2008202124418 U CN U2008202124418U CN 200820212441 U CN200820212441 U CN 200820212441U CN 201269874 Y CN201269874 Y CN 201269874Y
Authority
CN
China
Prior art keywords
hemolytic agent
counting chamber
liquid
hemolytic
diluted sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNU2008202124418U
Other languages
Chinese (zh)
Inventor
欧泽民
林有森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENZHEN PROCAN ELECTRONICS Inc
Original Assignee
SHENZHEN PROCAN ELECTRONICS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHEN PROCAN ELECTRONICS Inc filed Critical SHENZHEN PROCAN ELECTRONICS Inc
Priority to CNU2008202124418U priority Critical patent/CN201269874Y/en
Application granted granted Critical
Publication of CN201269874Y publication Critical patent/CN201269874Y/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The utility model relates to a hemolytic agent adding device which comprises a hemolytic agent charging tube (4) and a counting chamber (6) holding diluted sample liquid. The bottom of the counting chamber (6) is provided with an aeration/drainage pipe (7) and one end of the hemolytic agent charging tube (4) is provided with a hemolytic agent adding joint (8). The hemolytic agent charging tube (4) is connected with the aeration/drainage pipe (7) by the hemolytic agent adding joint (8). The hemolytic agent of the utility model directly enters from the position under the counting chamber (6) through the hemolytic agent adding joint (8), so that the hemolytic agent can not float on the surface of the diluted sample liquid in the counting chamber, and then by throwing well-mixed bubbles into the counting chamber from the position under the counting chamber, the hemolytic agent can be in full contact with the diluted sample liquid to realize the uniform mixing effect.

Description

The hemolytic agent adding apparatus
Technical field
The utility model relates to the clinical treatment instrument field, more particularly, relates to a kind of hemolytic agent adding apparatus.
Background technology
In the clinical treatment, often need check, leucocyte, red blood cell, blood platelet, haemoglobin etc. in the blood of human body are detected blood of human body.
Because the cell size in normal human's blood can be measured according to its volume size within the specific limits, present three classification cellanalyzers all adopt " orifice method " (also claiming " electrical impedance method " or " Ku Ertefa "), and it is measured to leucocyte, red blood cell, blood platelet.
When being checked, the blood of human body cell uses cellanalyzer usually, in cellanalyzer, red blood cell is leukocytic hundreds of times, disturb leucocyte to measure for fear of red blood cell, usually adopt two counting chambers, promptly " white blood cell count(WBC) pond ", " red blood cell count(RBC) pond " are measured, and add " hemolytic agent " and make erythrocytolysis in " white blood cell count(WBC) pond ", just can carry out white blood cell count(WBC) and measure.
Because erythrocytic concentration is much larger than leucocyte, in cellanalyzer, the dilution that blood sample is formed in the leucocyte pond is called first dilution, from first dilution, take out a certain amount of red blood cell count(RBC) pond of putting into, add a certain amount of dilution again and form measuring second dilution of red blood cell.And first dilution in the dialogue cell pool adds hemolytic agent, dissolves away red blood cell and forms leucocyte measurement dilution.
So, when detecting blood usually, measure at leucocyte and add hemolytic agent in the liquid, and cell volume is very little that test signal is very little, inhomogeneously will have influence on testing result if mix.In the prior art, hemolytic agent is to adopt the sebific duct that is installed in top, white blood cell count(WBC) pond to join in the white blood cell count(WBC) pond, and hemolytic agent is the surface that directly is added to liquid in the counting chamber, makes both mix inhomogeneous through regular meeting like this.Even can solve by inflating to steep, also be difficult for mixing, though squeeze into more bigger bubble, the mixing effect can make moderate progress, but liquid can be got to the outside, pond like this, even bubble makes liquid level be connected with liquid-feeding tube, cause " short circuit ", undesired signal enters counting chamber, and the instrument background is increased.
The utility model content
The technical problems to be solved in the utility model is, at the above-mentioned hemolytic agent of prior art mix with dilution in the counting chamber inhomogeneous, easily liquid is got the defective that, easily in counting chamber, forms undesired signal in the pond outside, provide a kind of and make that hemolytic agent and dilution mix, liquid is not got counting chamber, can reduce the hemolytic agent adding apparatus of outer bound pair counting chamber interference.
The technical scheme that its technical matters that solves the utility model adopts is: construct a kind of hemolytic agent adding apparatus, it comprises the hemolytic agent liquid-feeding tube, holds the counting chamber of diluted sample liquid, the bottom of counting chamber is provided with ventilation/discharging tube, first port of hemolytic agent liquid-feeding tube is provided with hemolytic agent and adds joint, and described hemolytic agent liquid-feeding tube adds joint by hemolytic agent and links to each other with ventilation/discharging tube.
In hemolytic agent adding apparatus described in the utility model, it is three-way connection that described hemolytic agent adds joint.
In hemolytic agent adding apparatus described in the utility model, second port of hemolytic agent liquid-feeding tube links to each other with syringe, and syringe connects the hemolytic agent bottle (or hemolytic agent bucket) that holds hemolytic agent.
In hemolytic agent adding apparatus described in the utility model, be connected with control between described hemolytic agent bottle and the syringe and add the hemolytic agent valve.
Implement hemolytic agent adding apparatus of the present utility model, has following beneficial effect: the hemolytic agent liquid-feeding tube is added ventilation/discharging tube that joint is directly connected to lower end, white blood cell count(WBC) pond by hemolytic agent, then hemolytic agent directly enters counting chamber below hemolytic agent adds joint and the ventilation/discharging tube through counting chamber, squeeze into the mixing bubble again below counting chamber, the mixing bubble below of diluted sample liquid is squeezed into diluted sample liquid with hemolytic agent in the counting chamber always.Because hemolytic agent is squeezed into from the below of diluted sample liquid, can not float over the surface of diluted sample liquid, only need squeeze into a certain amount of bubble, can be with hemolytic agent and diluted sample liquid mixing, need not squeeze into too much bubble for mixing, make liquid be got counting chamber, also reduced the interference of outer bound pair counting chamber, and hemolytic agent mixes fully with diluted sample liquid.
Description of drawings
The utility model is described in further detail below in conjunction with drawings and Examples, in the accompanying drawing:
Fig. 1 is the structural representation of the utility model hemolytic agent adding apparatus.
Embodiment
As shown in Figure 1, Fig. 1 is the structural representation of the utility model hemolytic agent adding apparatus.
The utility model mainly comprises hemolytic agent liquid-feeding tube 4, holds the counting chamber 6 of diluted sample liquid, the bottom of counting chamber 6 is provided with ventilation/discharging tube 7, one end of hemolytic agent liquid-feeding tube 4 is provided with hemolytic agent and adds joint 8, and described hemolytic agent liquid-feeding tube 4 adds joint 8 by hemolytic agent and links to each other with ventilation/discharging tube 7.
The utility model also comprises hemolytic agent bottle 1, the syringe 2 that links to each other with hemolytic agent bottle 1, and the bottom of counting chamber 6 is provided with ventilation/discharging tube 7, is connected the hemolytic agent liquid-feeding tube 4 between described syringe 2 and the counting chamber 6.Hemolytic agent bottle 1, syringe 2, and hemolytic agent liquid-feeding tube 4 between connection be threeway, between hemolytic agent bottle 1 and syringe 2, be provided with to control and add hemolytic agent valve 3.This hemolytic agent bottle 1 also can be that hemolytic agent bucket or other hold the container of hemolytic agent.
Syringe 2 extracts hemolytic agent from hemolytic agent bottle 1, the T/A of extraction can add hemolytic agent valve 3 by syringe 2 cooperation controls and control.Syringe 2 is pushed to the hemolytic agent that is drawn in the counting chamber 6 by hemolytic agent liquid-feeding tube 4 then.Counting chamber 6 is used for holding diluted sample liquid, and diluted sample liquid normally adds the top adding of pipe from counting chamber 6 by dilution.Be different from hemolytic agent in the prior art and be from the top of counting chamber 6 and join, hemolytic agent of the present utility model is to enter from the below of counting chamber 6 by hemolytic agent liquid-feeding tube 4.Because hemolytic agent liquid-feeding tube 4 adds joint 8 by the hemolytic agent that is arranged on its tail end and directly links to each other with the ventilation/discharging tube 7 that is arranged on counting chamber 6 bottoms, then hemolytic agent by syringe 2 suck a certain amount of after, pushed counting chamber 6 by syringe again, hemolytic agent is by hemolytic agent liquid-feeding tube 4, directly through the ventilation/discharging tube 7 of the three-way connection type of counting chamber 6 bottoms hemolytic agent squeezed into counting chamber 6.
Squeeze into the mixing bubble again below counting chamber 6, the mixing bubble directly is driven into counting chamber 6 by ventilation/discharging tube 7.Simultaneously, the mixing bubble is squeezed into diluted sample liquid with the below of the diluted sample liquid of hemolytic agent in the counting chamber 6 always, makes hemolytic agent fully to contact with diluted sample liquid.
Because hemolytic agent is squeezed into from the below of diluted sample liquid, hemolytic agent can not float over the surface of diluted sample liquid, and it fully contacts with diluted sample liquid, reaches the mixing effect.In addition, hemolytic agent is squeezed into from the below of diluted sample liquid, and the mixing bubble is to squeeze into from ventilation/discharging tube 7, only need suitably squeeze into bubble gets final product mixing, need not beat too much bubble and come mixing, so just avoided liquid can be got counting chamber 6, perhaps the opening of counting chamber 6 upper ends is bigger, when adding hemolytic agent from the top of counting chamber 6, hemolytic agent is added to diluted sample liquid surface, and has influenced both contact mixing, has also avoided bubble that liquid level is connected with liquid-feeding tube, cause " short circuit " undesired signal to enter counting chamber 6, the instrument background is increased.
So the utility model realized hemolytic agent and fully contacted mixing with dilution, and reduced the interference of outer bound pair counting chamber 6, also avoided liquid to be got outside the counting chamber 6.
The above only is a preferred embodiment of the present utility model; be not so limit claim of the present utility model; every equivalent structure or equivalent flow process conversion that utilizes the utility model instructions and accompanying drawing content to be done; or directly or indirectly be used in other relevant technical fields, all in like manner be included in the scope of patent protection of the present utility model.

Claims (4)

1, a kind of hemolytic agent adding apparatus, comprise hemolytic agent liquid-feeding tube (4), hold the counting chamber (6) of diluted sample liquid, the bottom of counting chamber (6) is provided with ventilation/discharging tube (7), it is characterized in that: first port of hemolytic agent liquid-feeding tube (4) is provided with hemolytic agent and adds joint (8), and described hemolytic agent liquid-feeding tube (4) adds joint (8) by hemolytic agent and links to each other with ventilation/discharging tube (7).
2, hemolytic agent adding apparatus according to claim 1 is characterized in that, it is three-way connection that described hemolytic agent adds joint (8).
3, hemolytic agent adding apparatus according to claim 1 is characterized in that, second port of hemolytic agent liquid-feeding tube (4) links to each other with syringe (2), and syringe (2) connects the hemolytic agent bottle (1) that holds hemolytic agent.
4, hemolytic agent adding apparatus according to claim 3 is characterized in that, is connected with control between described hemolytic agent bottle (1) and the syringe (2) and adds hemolytic agent valve (3).
CNU2008202124418U 2008-10-13 2008-10-13 Hemolytic agent charging apparatus Expired - Fee Related CN201269874Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNU2008202124418U CN201269874Y (en) 2008-10-13 2008-10-13 Hemolytic agent charging apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNU2008202124418U CN201269874Y (en) 2008-10-13 2008-10-13 Hemolytic agent charging apparatus

Publications (1)

Publication Number Publication Date
CN201269874Y true CN201269874Y (en) 2009-07-08

Family

ID=40842482

Family Applications (1)

Application Number Title Priority Date Filing Date
CNU2008202124418U Expired - Fee Related CN201269874Y (en) 2008-10-13 2008-10-13 Hemolytic agent charging apparatus

Country Status (1)

Country Link
CN (1) CN201269874Y (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102253230A (en) * 2011-07-01 2011-11-23 南京神州英诺华医疗科技有限公司 Automatic analyzer and analysis method of blood platelets
CN103257102A (en) * 2013-04-28 2013-08-21 深圳市开立科技有限公司 Counting chamber with blending function and blending method thereof
CN104297023A (en) * 2013-07-16 2015-01-21 成都深迈瑞医疗电子技术研究院有限公司 A cell analyzer, a mixing device thereof and a mixing method
CN111381017A (en) * 2018-12-27 2020-07-07 深圳市帝迈生物技术有限公司 Five-classification hemolytic agent for white blood cells, preparation method, blood analyzer and detection method

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102253230A (en) * 2011-07-01 2011-11-23 南京神州英诺华医疗科技有限公司 Automatic analyzer and analysis method of blood platelets
CN102253230B (en) * 2011-07-01 2015-04-22 江苏英诺华医疗技术有限公司 Automatic analyzer and analysis method of blood platelets
CN103257102A (en) * 2013-04-28 2013-08-21 深圳市开立科技有限公司 Counting chamber with blending function and blending method thereof
CN104297023A (en) * 2013-07-16 2015-01-21 成都深迈瑞医疗电子技术研究院有限公司 A cell analyzer, a mixing device thereof and a mixing method
CN104297023B (en) * 2013-07-16 2017-05-24 成都深迈瑞医疗电子技术研究院有限公司 A cell analyzer, a mixing device thereof and a mixing method
CN111381017A (en) * 2018-12-27 2020-07-07 深圳市帝迈生物技术有限公司 Five-classification hemolytic agent for white blood cells, preparation method, blood analyzer and detection method

Similar Documents

Publication Publication Date Title
CN104897557B (en) FCM analysis liquid-way system and FCM analysis method
JP4660662B2 (en) cartridge
CN201269874Y (en) Hemolytic agent charging apparatus
CN109932520A (en) Blood test device
CN109932519A (en) Blood test device
CN109959549A (en) Sample testing method and sample analyser
CN106018773A (en) Disposable blood cell counting and analyzing integrated reagent sensing unit and novel blood analyzer
CN110261457A (en) Ion selective electrode electrolyte module
CN110967309A (en) Online detection system and method for available chlorine in water quality disinfection process
CN102608342A (en) Sampling device for enzyme injection type glucose biosensor online analyzer
CN209035024U (en) A kind of blood cell analysis machine
CN109211737B (en) Sample detection device, sample analyzer, and sample detection method
CN206756858U (en) A kind of liquid sample guiding device, detection strip and detecting instrument
CN205826668U (en) Disposable blood cell counting and analyze integrated reagent sensing part and blood analyser
CN216350218U (en) Electrical impedance counter and sample analyzer
CN204101463U (en) Pork freshness pick-up unit
CN107918031A (en) A kind of liquid sample guiding device and the detection device containing the guiding device
CN206696223U (en) A kind of enzyme injection type glucose biosensor based on micro-fluidic chip
CN206848287U (en) Reaction component and sample analyser
CN217652869U (en) Quantitative assembly, sample processing device and reagent preparation device
CN116087542A (en) Sample analyzer and sample detection method
CN116148493A (en) Blood sample distribution method and blood sample distribution device
CN214749705U (en) Double-flow-path waterway system capable of simultaneously measuring TP and TN
CN202267502U (en) Volume fixing device
CN208621505U (en) One kind being used for detection of drug concentration device

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090708

Termination date: 20171013

CF01 Termination of patent right due to non-payment of annual fee